Robert H. Sinnamon

951 total citations
7 papers, 566 citations indexed

About

Robert H. Sinnamon is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Robert H. Sinnamon has authored 7 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Materials Chemistry. Recurrent topics in Robert H. Sinnamon's work include Cancer-related Molecular Pathways (2 papers), Enzyme Structure and Function (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Robert H. Sinnamon is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Enzyme Structure and Function (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Robert H. Sinnamon collaborates with scholars based in United States, Netherlands and Hungary. Robert H. Sinnamon's co-authors include Peter J. Tummino, Alastair J. King, Marc R. Arnone, Robert B. Kirkpatrick, Robert A. Copeland, Zhihong Lai, Tara Rheault, David Uehling, Kimberly N. Smitheman and Laurie S. Kane-Carson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Robert H. Sinnamon

7 papers receiving 554 citations

Peers

Robert H. Sinnamon

MB

ONCOL

CTM

GENET

CB

Eloisi Caldas-Lopes United States

Gretchen A. Repasky United States

Randy Hoffman United States

Ann Palladino United States

Luwei Liu United States

Vivek Modi United States

Alexander R. Chait United States

Roberta Pireddu United States

Jeff Kucharski United States

Steven DellaRocca United States

Eloisi Caldas-Lopes United States

Robert H. Sinnamon

482 ×0.9

MB

152 ×1.1

ONCOL

75 ×1.1

CTM

106 ×1.9

GENET

73 ×1.6

CB

Citations per year, relative to Robert H. Sinnamon Robert H. Sinnamon (= 1×) peers Eloisi Caldas-Lopes

Countries citing papers authored by Robert H. Sinnamon

Since Specialization

Citations

This map shows the geographic impact of Robert H. Sinnamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Sinnamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Sinnamon more than expected).

Fields of papers citing papers by Robert H. Sinnamon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Sinnamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Sinnamon. The network helps show where Robert H. Sinnamon may publish in the future.

Co-authorship network of co-authors of Robert H. Sinnamon

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Sinnamon. A scholar is included among the top collaborators of Robert H. Sinnamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Sinnamon. Robert H. Sinnamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Thorpe, James H., Ian D. Wall, Robert H. Sinnamon, Amy Taylor, & Robert A. Stavenger. (2020). Cocktailed fragment screening by X-ray crystallography of the antibacterial target undecaprenyl pyrophosphate synthase from Acinetobacter baumannii. Acta Crystallographica Section F Structural Biology Communications. 76(1). 40–46. 1 indexed citations

2.

King, Alastair J., Marc R. Arnone, Maureen R. Bleam, et al.. (2013). Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions. PLoS ONE. 8(7). e67583–e67583. 163 indexed citations

3.

Aller, Glenn S. Van, Nicolas Reynoird, Olena Barbash, et al.. (2012). Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics. 7(4). 340–343. 140 indexed citations

4.

Ma, Jianhong, John D. Martin, Yu Xue, et al.. (2010). C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Archives of Biochemistry and Biophysics. 503(2). 207–212. 61 indexed citations

5.

Aller, Glenn S. Van, Christine Fernandes, Ruth Lehr, et al.. (2008). Characterization of PI3K class IA isoforms with regulatory subunit p55α using a scintillation proximity assay. Analytical Biochemistry. 383(2). 311–315. 9 indexed citations

6.

Carson, Jeffrey D., Ruth Lehr, Robert H. Sinnamon, et al.. (2007). Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase. Biochemical Journal. 409(2). 519–524. 100 indexed citations

7.

Fernandes, Christine, Kang Yan, Hong Zhang, et al.. (2006). A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues. Proceedings of the National Academy of Sciences. 103(20). 7625–7630. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact